Next gen cancer drug shows surprising anti aging power

Researchers at Queen Mary University of London’s School of Biological and Behavioural Sciences have demonstrated that the experimental TOR inhibitor rapalink-1 can extend the chronological lifespan of fission yeast, a simple organism widely used…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *